← Back to headlines
Edgewise Therapeutics Reports GAAP EPS of -$0.53
Edgewise Therapeutics announced its GAAP Earnings Per Share (EPS) for the latest period, reporting a loss of $0.53 per share.
6 Aug, 12:15 — 6 Aug, 12:15
Sources
Showing 1 of 1 sources
Related Stories
Pizza Pizza Royalty Reports Adjusted EPS of C$0.228
11m ago
OraSure Expects Q3 Revenue of $29.5M-$32.5M, Delays FDA Clearance
12m ago
Fox Shares Rise After Q2 Results Beat Estimates on World Cup Advertising Boost
12m ago
Major Hungarian Bicycle Factory Faces Closure, Nearly 500 Workers to Be Laid Off
13m ago